Abeona Therapeutics (ABEO) EPS (Weighted Average and Diluted): 2011-2025
Historic EPS (Weighted Average and Diluted) for Abeona Therapeutics (ABEO) over the last 7 years, with Sep 2025 value amounting to -$0.10.
- Abeona Therapeutics' EPS (Weighted Average and Diluted) rose 84.13% to -$0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.23, marking a year-over-year increase of 145.72%. This contributed to the annual value of -$1.55 for FY2024, which is 38.74% up from last year.
- Latest data reveals that Abeona Therapeutics reported EPS (Weighted Average and Diluted) of -$0.10 as of Q3 2025, which was down 105.85% from $1.71 recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of $3.80 in Q2 2022 and a low of -$1.16 during Q1 2024.
- In the last 3 years, Abeona Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.48 in 2023 and averaged -$0.31.
- As far as peak fluctuations go, Abeona Therapeutics' EPS (Weighted Average and Diluted) slumped by 223.08% in 2023, and later spiked by 757.69% in 2025.
- Over the past 4 years, Abeona Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at $0.52 in 2022, then plummeted by 223.08% to -$0.64 in 2023, then surged by 78.12% to -$0.14 in 2024, then surged by 84.13% to -$0.10 in 2025.
- Its last three reported values are -$0.10 in Q3 2025, $1.71 for Q2 2025, and -$0.24 during Q1 2025.